[Form 4] Atlassian Corporation Insider Trading Activity
Rhea-AI Filing Summary
Michael Cannon-Brookes, CEO and Co-Founder of Atlassian Corporation (TEAM), reported multiple sales of Class A common stock on 09/09/2025 executed pursuant to a Rule 10b5-1 trading plan adopted on February 20, 2025. The Form 4 lists seven separate sale entries with individual quantities sold (ranging from 50 to 2,820 shares) at weighted-average prices between approximately $175.82 and $182.46. Shares are held indirectly through CBC Co Pty Limited as trustee for the Cannon-Brookes Head Trust. Following the reported transactions the filing shows an indirect beneficial ownership position reported as 114,975 Class A shares (based on the last line reported).
Positive
- Sales executed under a Rule 10b5-1 plan, indicating pre-planned transactions and regulatory compliance
- Timely and detailed disclosure of quantities, weighted-average prices, and indirect ownership through a trustee
Negative
- Insider selling by a >10% owner and CEO could be interpreted negatively by some investors
- Beneficial ownership decreased from prior reported levels to 114,975 Class A shares as shown in the filing
Insights
TL;DR: Routine, pre-planned insider sales under a 10b5-1 plan; no new material corporate disclosure or operational change.
The transaction pattern on this Form 4 indicates multiple sales executed on a single date under an existing 10b5-1 plan adopted February 20, 2025. The weighted-average sale prices reported range roughly from $175.82 to $182.46, and the quantities are modest relative to large institutional positions. Because the sales were effected pursuant to a pre-established plan and the filing discloses continued indirect ownership via a trust, this appears to be a liquidity event by a significant shareholder rather than a company-specific operational signal. Market impact would depend on total outstanding float and trading volume on the execution date; the filing itself does not provide those market context metrics.
TL;DR: Insider complied with disclosure and used a 10b5-1 plan; governance processes appear followed based on the filing.
The Form 4 clearly identifies the reporting person as a director, officer and >10% owner and cites a Rule 10b5-1 trading plan, which provides an affirmative defense to insider trading allegations if properly adopted and followed. The filing also specifies shares are held indirectly through a trustee, and it includes attestations regarding aggregated trades executed at varying intra-day prices. From a governance standpoint, the document shows timely disclosure and the use of an established trading vehicle, consistent with common best practices for executives needing liquidity while managing insider trading risk. The filing does not disclose any change in role, compensation, or company governance actions.